Showing 1271-1280 of 1395 results for "".
- Nicox European Patent Seals Zerviate Major Market Coverage to 2030https://modernod.com/news/nicox-european-patent-seals-zerviate-major-market-coverage-to-2030/2480545/Nicox announced that patent EP2408453, covering the company’s product Zerviate (cetirizine ophthalmic solution) 0.24%, has been issued by the European Patent Office (EPO). The patent covers the formulation of Zerviate which is commercialized in the US by exclusive US licensee
- LayerBio Granted U.S. Patent for OcuRing Drug Delivery Platformhttps://modernod.com/news/layerbio-granted-us-patent-for-ocuring-drug-delivery-platform/2480486/LayerBio announced that the United States Patent and Trademark Office (USPTO) has issued US Patent No. 11,185,441. "This patent issuance marks an important milestone for the OcuRing platform and recognition of novelty and uniqueness of our drug delivery technology,&
- Updated Cataract PPP Raises Questions About Same-Day Bilateral Cataract Surgery and Office-based Cataract Surgeryhttps://modernod.com/news/updated-cataract-ppp-raises-questions-about-same-day-bilateral-cataract-surgery-and-office-based-cataract-surgery/2480467/The American Academy of Ophthalmology recognizes that immediate sequential bilateral cataract surgery (ISBCS) has the potential for some positive implications for patients. These include reduced out-of-pocket expense and fewer total visits to health care facilities. ISBCS has been adopted to a gr
- Nicox is Granted Patent for Blepharitis Product Candidate NCX 4251 in Europehttps://modernod.com/news/nicox-is-granted-patent-for-blepharitis-product-candidate-ncx-4251-in-europe/2480459/Nicox SA announced that patent EP 3,769,753, expiring in 2040 and covering the company’s product candidate in development for blepharitis, NCX 4251, has been issued by the European Patent Office (EPO). The patent covers ophthalmic suspensions comprising a specific form of fluticas
- Hanita Lenses Launches New Website as Part of 40th Anniversaryhttps://modernod.com/news/hanita-lenses-launches-new-website-as-part-of-40th-anniversary/2480365/Hanita Lenses has marked its 40th anniversary by launching a new website as part of its rebranding. Israel-based Hanita Lenses is a manufacturer and provider of intraocular lens solutions for cataract surgery.
- Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Carehttps://modernod.com/news/alcon-celebrates-world-sight-day-2021-in-communities-worldwide-with-programs-for-improved-access-to-eye-care/2480353/Alcon celebrates World Sight Day 2021 by taking action in communities across the globe to raise awareness of blindness and vision impairment as global public health issues. Celebrated annually in October, World Sig
- New Contact Lens Update Focuses on Axial Length Measures in Myopia Managementhttps://modernod.com/news/new-contact-lens-update-focuses-on-axial-length-measures-in-myopia-management/2479488/Issue 61 of
- FDA Advisory Panel Set to Review COVID-19 Booster Doseshttps://modernod.com/news/fda-advisory-panel-set-to-review-covid-19-booster-doses/2479485/The FDA announced that an advisory committee will meet on September 17 to discuss the issue of booster doses of COVID-19 vaccines, according to a FirstWord report. The Vaccines and Related Biological Products Advisory Committee will spec
- BVI Announces Collaboration With BeyeOnics Visionhttps://modernod.com/news/bvi-announces-collaboration-with-beyeonics-vision/2479411/BVI announces a collaboration with Israel-based BeyeOnics Vision, a maker of in head-mounted display, digital data, and imaging processing. BeyeOnics Vision has been developing BeyeOnics 1, which the company describes as the first and only ophthalmic digital imaging system replacing the op
- Harrow Health Granted Two Patents for Novel Surgical Dilation Formulationhttps://modernod.com/news/harrow-health-granted-two-patents-for-novel-surgical-dilation-formulation/2479377/Harrow Health announced that the United States Patent and Trademark Office issued two patents, entitled “Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof.” Harrow Health’s wholly owned subsidiary, ImprimisRx, provides surgical dilation (